loader2
Login Open ICICI 3-in-1 Account

Jyothy Labs Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Jyothy Labs Ltd. 12 Nov 2025 13:46 PM

Q2FY26 Quarterly Result Announced for Jyothy Labs Ltd.

Personal Products company Jyothy Labs announced Q2FY26 results

  • Net Revenue: Rs 736 crore, up by 0.4% (Volume Growth: 2.8%).
  • Operating EBITDA margin 16.1% (% 118.3 crore) versus 18.9% (% 138.3 crore) in previous year.
  • Profit After Tax: Rs 87.8 crore versus Rs 104.9 crore in previous year.

M. R. Jyothy, Chairperson and Managing Director, Jyothy Labs, said: “Q2 was a disciplined step forward in what was a transition quarter. The GST rate revision led to short-term channel adjustments, but our core business remained resilient with volume growth of 2.8%.

We safeguarded profitability through cost discipline and strong cash management, closing the first half with Rs 801 crore in cash and zero debt. Looking ahead, we expect H2 to perform better than H1, supported by stable commodity costs and a gradual recovery in demand.

Our focus remains the same - keep the consumer at the centre, strengthen our core categories, accelerate detergent liquids and new launches, and bring Personal Care back to growth. We will continue to execute with precision across segments and channels and deploy capital prudently.

Subject to macroeconomic conditions, our endeavour is to close FY26 with double-digit volume growth.”

Result PDF

Personal Products company Jyothy Labs announced Q1FY26 results

  • Net Revenue: Rs 751 crore, up by 1.4% (Volume Growth: 3.6%)
  • Operating EBITDA margin 16.5% (Rs 124.2 crore) versus 18% (Rs 133.6 crore) in the previous year
  • Profit After Tax: Rs 96.8 crore versus Rs 101.8 crore in the previous year

M. R. Jyothy, Chairperson and Managing Director, Jyothy Labs, said, "In a quarter marked by evolving consumer behaviour and rising competitive intensity, Jyothy Labs demonstrated resilience, volume-led growth, and margin protection. Our recent product launches, especially in fabric care, are scaling well, supported by focused marketing and distribution efforts. While Q1 reflects the realities of a cautious consumption environment, improving macro indicators—such as an above-normal monsoon and policy tailwinds—position us favourably for stronger momentum from Q3 onwards. As channels evolve and costs stabilise, we remain committed to driving profitable growth through innovation, agility, and execution excellence".

Result PDF

Personal Products company Jyothy Labs announced Q4FY25 & FY25 results

Q4FY25 Financial Highlights:

  • Net Sales at Rs 667 crore, up by 1.1%.
  • EBITDA margin at 16.8% (Rs 112 crore) versus 16.4% (Rs 108.4 crore).
  • Profit after tax at Rs 76.3 crore versus Rs 78.2 crore.

FY25 Financial Highlights:

  • Net Sales at Rs 2,847 crore, up by 3.3%.
  • EBITDA margin at 17.5% (Rs 499.6 crore) versus 17.4% (Rs 479.8 crore).
  • Profit after tax at Rs 370.4 crore versus Rs 369.3 crore
  • The Board of Directors has recommended a final dividend of Rs 3.5 per equity share of Re 1 each for the financial year ended March 31, 2025.

M R Jyothy, Chairperson & Managing Director, Jyothy Labs, said: “Q4 delivered an impressive volume growth of 4% and a modest revenue growth of 1.1%, amidst a continued subdued demand environment. Our disciplined focus on cost management and calibrated pricing actions enabled us to improve the EBITDA margin to 16.8% during the quarter, compared to 16.4% in the same period last year.

We concluded FY25 on a positive note with a 6.4% growth in volumes as well as delivering growth in both revenues and profits over the previous year. While competitive intensity remains elevated across the FMCG sector—particularly in daily essentials such as detergents, soaps, and dishwashing products—our ability to adapt to an evolving channel landscape, our wide product portfolio, and our agile and responsive operations position us well to navigate this environment.

We remain confident in the long-term growth prospects of our business, despite the near-term challenges posed by macroeconomic factors. We continue to invest in and strengthen our brand portfolio across segments, with a clear focus on the future. Our commitment to offering a diverse range of products—across categories, channels, segments, price points, and pack sizes—will be instrumental in delivering on our growth aspirations in the years ahead. Our debt-free position and robust cash reserves provide the financial flexibility to invest in long-term brand-building and strategic initiatives”

Result PDF

Personal Products company Jyothy Labs announced Q3FY25 results

  • Net Sales at Rs. 704 crore, up by 4%.
  • EBITDA margin at 16.4% (Rs 115.8 crore) versus 17.5% (Rs 118.6 crore).
  • Profit after tax at Rs 87.4 crore versus Rs 90.9 crore.

M R Jyothy, Chairperson & Managing Director, Jyothy Labs, said: “4% value growth and 8% volume growth in the quarter is a testimony of our resilience amid not so favorable demand environment. At the nine-month mark in the current financial year, 7.2% volume growth indicates that our strategic approach and initiatives can keep up the growth momentum even when the external environment is not so conducive. On the back of our sourcing and other operational efficiencies, we were able to deliver an EBITDA margin of 16.4% in the quarter. We continue to work towards strengthening our brands, deepening our distribution network and expanding our direct retail presence while extracting more volume from the existing channel(s). Volume growth will be a key metric for us as we focus on both rural and urban segments through targeted innovation and a strengthened distribution network.”

Result PDF

Personal Products company Jyothy Labs announced H1FY25 & Q2FY25 results

Q2FY25 Financial Highlights:

  • Net Sales at Rs 734 crore, up by 0.2% YoY.
  • EBITDA margin at 18.9% (Rs 138.5 crore) versus 18.5% (Rs 135.4 crore), up by 2.3% YoY.
  • Net Profit at Rs 105 crore from Rs 104 crore up by 1% YoY.

H1FY25 Financial Highlights:

  • Net Sales at Rs 1476 crore, up by 4% YoY.
  • EBITDA margin at 18.4% from 17.8% at Rs 271.9 crore, up by 7.6% YoY.
  • Net Profit after Tax at Rs 206.7 crore, up by 3.2% YoY.
  • Cash balance as of H1FY25 of Rs 658.6 crore.

M R Jyothy, Chairperson and Managing Director, Jyothy Labs, said: “Our EBITDA of 18.9% for the quarter indicates better operational efficiency. At the half-year mark, our 7% volume growth indicates that our strategic approach and initiatives can keep up the growth momentum. The growth in the market share of our brands highlights the consumer trust they have built. Going forward, our strategy includes deepening our distribution network in rural markets and expanding our direct retail presence. Volume growth will be a key metric for us as we focus on both rural and urban segments through targeted innovation and a strengthened distribution network.”

Result PDF

Personal Products company Jyothy Labs announced Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Net Sales at Rs 660 crore, up by 7%
  • EBITDA margin at 16.4% from 14.8% at Rs 108.4 crore, up by 18.8%
  • Net Profit at Rs 78.2 crore, up by 31.9% 

FY24 Financial Highlights:

  • Net Sales at Rs 2,757 crore, up by 10.9%
  • EBITDA margin at 17.4% from 12.7% at Rs 479.8 crore
  • Net Profit at Rs 369.3 crore, up by 54%
  • Cash balance as at March 31, 2024 of Rs 618 Crore.
  • The Board of Directors have recommended a dividend of Rs 3.5 per equity share of Rs 1 each for the year ended March 31, 2024.

Result PDF

Personal Products company Jyothy Labs announced Q3FY24 & 9MFY24 results:

  • Q3FY24 vs Q3FY23:
    • Net Sales at Rs. 678 crore, up by 10.6%
    • EBITDA margin at 17.5% (Rs 118.6 crore) versus 13.8% (Rs 84.4 crore), up by 40.6%
    • Net Profit at Rs 90.9 crore from Rs 67.4 crore, up by 34.9%
  • 9MFY24 vs 9MFY23:
    • Net Sales at Rs. 2097 crore, up by 12.2%
    • EBITDA margin at 17.7% (Rs 371.4 crore) versus 12.0% (Rs 224.6 crore), up by 65.4%
    • Net Profit at Rs 291.2 crore from Rs 180.5 crore, up by 61.3%

Commenting on the financial performance of Q3FY24, M R Jyothy, Managing Director, Jyothy Labs said, “The performance for the quarter has been encouraging with double-digit revenue growth and expanding profitability metrices. Our results in the last few years have demonstrated consistent growth backed by our investment towards strategic brand building, enhancing direct distribution, and manufacturing capacity augmentation.

Consumer demand has been mixed with rural growth yet to pick up momentum. We strive towards volume-led growth, strengthen our brand market share, and achieve the higher scale of business operations for sustainable long-term value creation for all stakeholders”.

 

Result PDF

Personal Products company Jyothy Labs announced Q2FY24 & H1FY24 results:

1. Financial Performance:

  • Q2FY24:
    • Net Sales at Rs 732 crore, up by 11.1%
    • EBITDA margin at 18.5% (Rs 135.4 crore) versus 12.2% (Rs 80.4 crore), up by 68.3%
    • Net Profit after Tax at Rs 104 crore from Rs 65.4 crore up by 59.1%
  • H1FY24:
    • Net Sales at Rs 1,419 crore, up by 13%
    • EBITDA margin at 17.8% from 11.2% at Rs 252.8 crore, up by 80.2%
    • Net Profit after Tax at Rs 200.2 crore, up by 77.1%
    • Cash balance as of September 30, 2023, of Rs 440 Crore

2. Business Strategy and Execution:
- Jyothy Labs focused on strengthening its core business through effective execution, resulting in higher growth.
- The company leveraged its expanded distribution platform to mitigate the slowing consumption environment and drive sales in new geographies.
- Market share growth was achieved across Jyothy Labs' portfolio, highlighting the success of increased brand investments, research & development efforts, and agile business operations.

3. Segment Performance:
- Fabric Care: Sales of fabric care products, including fabric whitener, fabric enhancer, bar soap, detergent powder, and liquid detergent, increased by 10.6% in Q2FY24. The segment witnessed improvement in sales across all brands, with a focus on value offerings and premium liquid detergents.
- Dishwashing: Sales of dishwashing products increased by 10% in Q2FY24. The growth was driven by the Exo and Pril brands, with onboarding new consumers and a focus on larger packs in the dishwashing liquid category.
- Personal Care: Sales of personal care products, including body soap and toothpaste, showed a significant growth of 22.3% in Q2FY24. The Margo portfolio of Neem-based soaps, as well as the launch of Margo Neem Naturals with three new variants, contributed to this growth.
- Household Insecticides: Sales of household insecticides increased by 3.4% in Q2FY24, with a consistent recovery after a challenging period. The company focused on innovation, brand affinity, and distribution in this segment, particularly with its liquid vaporizer portfolio.

M R Jyothy, Managing Director, Jyothy Labs, stated, "The demand across our product portfolio has been stable. The inflationary environment has been a constant pressure on the consumption of FMCG products, however, given our business potential, we continue to expand our distribution footprint across India and further strengthen our brands which has resulted in consistent business growth.

We are dedicated to delivering great value to all our consumers who have entrusted faith in us. With our continued and sustained focused efforts, we are confident to deliver committed results with every passing quarter and higher growth for all our stakeholders."

 

 

Result PDF

Personal Products Company Jyothy Labs announced Q1FY24 results:

  • Net sales at Rs 687 crore, up by 15.1%
  • EBITDA margin at 17.1% (Rs 117.4 crore) vs 10% (Rs 60 crore), up by 96.3%
  • Net profit at Rs 96.3 crore from Rs 47.7 crore, up by 101.7%
  • Fabric care sales increased by 18.1% for Q1FY24 over Q1FY23.
  • Dishwashing sales increased by 10.6% for Q1FY24.
  • Household insecticides sales increased by 10.1% for Q1FY24.
  • Personal care sales increased by 21.1% for Q1FY24 over Q1FY23.

Commenting on the financial performance of Q1FY24, M R Jyothy, Managing Director, Jyothy Labs, said, “Our operating performance has been encouraging. We are focused on providing the best consumer experience through our brands in their day-to-day life. At the core of our operations, sustainability initiatives have been at the forefront to drive our long-term growth and profitability.

At Jyothy Labs, we aim for our business model to deliver consistent revenue growth with a focus on strengthening distribution, relevant innovations, increasing marketing investment, and optimising cost structures.

We have consistently delivered double-digit revenue growth for the last few years and expanding our profitability metrics. We strive to build scale with relentless execution and grow our brand's market share.”

 

 

Result PDF

Personal Products company Jyothy Labs announced Q4FY23 & FY23 results:

  • Q4FY23:
    • Revenue at Rs 617 crore increased by 12.8%
    • Gross Margin at 45.7% from 41.4% in Q4FY22
    • A&P Spend at Rs 45.9 crore (7.4% of Net Sales) versus Rs 39.1 crore (7.2% of Net Sales) in Q4FY22, an increase of 17.5%
    • Operating EBITDA at 14.8% (Rs 91.3 crore) versus 10.5% (Rs 57.3 crore) in Q4FY22, an increase of 59.4%
    • PAT at Rs 59.3 crore as against Rs 36.9 crore, in Q4FY22, Up by 60.4%
  • FY23:
    • Revenue at Rs 2,486 crore increased by 13.2%
    • Gross Margin at 42.3% from 41.6% in FY22
    • A&P Spend at Rs 174.3 crore (7% of Net Sales) versus Rs 161.1 crore (7.3% of Net Sales) in FY22, an increase of 8.2%
    • Operating EBITDA at 12.7% (Rs 315.9 crore) versus 11.3% (Rs 248.2 crore), in FY22, an increase of 27.2%
    • PAT at Rs 239.7 crore as against Rs 159.1 crore, in FY22, an increase of 50.7%
    • Nil Gross Debt as of March 31, 2023, Net Cash balance of Rs 283 crore
    • Proposed Dividend of Rs 3 per share of face value Re 1

 

 

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app